Research highlights the potential of Amphievovir for rabies treatment, suggesting new immunotherapy strategies may improve outcomes.
The article analyzes scientific research on the treatment and prevention of rabies. The role of modern approaches to rabies treatment, international experience and recommendations, and new experimental strategies, including immunotherapy using interferon inducers, is shown using the example of the domestic Amphievovir dietary supplement, positioned as a potential treatment for viral infections, including rabies. Amphievovir is intended for topical and sublingual use, which ensures the gradual entry of the inducer into the body and a predominantly local effect, which increases the safety and convenience of use for patients. Data from domestic studies demonstrate that Amphievovir has successfully passed preclinical safety tests and has pronounced antiviral activity of a wide range. It is important to continue multicenter research on rabies therapy, possibly combining the efforts of virologists, clinicians and pharmacologists from different countries.
No takes yet. Share an insight, caveat, or question.
Potupchik et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: